Objectives: Glomerular filtration rate (GFR) is the best index of renal function and is frequently assessed by corrected creatinine clearance (CCL cr ). The limitations of CCL cr have inspired researchers to derive easy formulas to estimate GFR, with Cockcroft-Gault (C-G) and the modification of diet in renal disease (MDRD) being the most widely used. This study aimed to evaluate the validity of these equations by finding the relation between CCL cr and estimated GFR (eGFR) by C-G, modified C-G and MDRD equations. Methods: From 2007 to 2011, 158 subjects were analysed for serum creatinine and CCL cr at Bowsher Polyclinic, Muscat, Oman. The C-G equation was used to obtain eGFR C-G which was adjusted to body surface area (BSA) to obtain eGFR mC-G , and the MDRD equation was used to obtain eGFR MDRD . The eGFR MDRD , eGFR mC-G and eGFR C-G were then compared to CCL cr . Results: The eGFR MDRD , eGFR mC-G and eGFR C-G significantly correlated with CCL cr , with a slightly stronger correlation with eGFR MDRD (r = 0.701, 0.658 and 0.605, respectively). A receiver operating characteristic curve analysis showed that the diagnostic accuracy of eGFR MDRD for diagnosing chronic kidney disease (CKD) was higher than that of eGFR mC-G , which in turn was higher than that of eGFR C-G (area under the curve was 0.846, 0.831, and 0.791; cut-off limits were 61.9, 58.3 and 59.5, respectively). Conclusion: C-G and MDRD equations can be an alternative to the CCL cr test for assessing GFR, thus avoiding the need for the cumbersome and expensive GFR test. The MDRD formula had greater validity than the C-G equation and the C-G equation validity was improved by an adjustment to BSA.
G lomerular filtration rate (GFR) is considered the best index of renal function as it assesses the progression of kidney dysfunction. The normal value is ~130 and 120 ml/min/1.73 m² for men and women, respectively, depending on age, sex and body size. 1 GFR can be determined by measuring the clearance of exogenous (inulin, 125-iothalamate, 51 Crethylene diamine tetra acetic acid [EDTA], 99mTc-diethylene triamine penta acetic acid [DTPA] and iohexol) or endogenous (creatinine) substances. 2 Methods using exogenous substances are expensive, time-consuming, risky and cannot be easily implemented in clinical practice. Nevertheless, inulin clearance is the gold standard test for GFR as it is freely filtered and is not secreted, reabsorbed, synthesised or metabolised by the kidney. 3 Creatine clearance (CL cr ) is an alternative to inulin clearance. Creatinine is freely filtered and is not metabolised by the kidney; however, it is secreted by the renal tubules. 4 If the effect of secretion is ignored, then all of the filtered creatinine will be excreted and this will reflect the GFR. Thus the GFR and CL cr will be equal: [UCr x V]/SCr, 5 where UCr is urine creatinine, V is the 24-hour urine volume and SCr is the serum creatinine. However, CL cr tends to exceed the true GFR due to tubular secretion. 5 It should therefore be adjusted to body surface area (BSA) so as to obtain the corrected creatinine clearance (CCL cr ) in ml/min/1.73 m² by the following equation: 6 The normal value of CCL cr is 95 ± 20 ml/min per 1.73 m² in women and 120 ± 25 ml/min per 1.73 m 2 in men. 5 SCr varies inversely with GFR and is used to assess stable kidney function, as a rise in SCr represents a reduction in GFR. However, in acute renal failure, GFR is markedly reduced and there is no time for creatinine to accumulate. 6 The mean SCr values for men and women are 100 and 82 µmol/L, respectively. These values vary by race and differ according to its production, secretion, extrarenal excretion and assay. 7, 8 The limitations of CL cr and inulin clearance have inspired researchers to seek out easy formulas to estimate GFR (eGFR). 9 The most widely used formulas are Cockcroft-Gault (C-G) 10 and the modification of diet in renal disease (MDRD).
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These formulas include variables such as age, sex, race, weight and SCr. In adults, normal eGFR is ≥90 ml/min/1.73m². Chronic kidney disease (CKD) is defined by an eGFR of <60 ml/min/1.73 m 2 . 9 As for SCr, the proper interpretation of these equations requires stable kidney function, and its accuracy is also limited as SCr is affected by factors other than creatinine filtration. 12, 13 In the C-G equation, CL cr can be estimated by the following formula: 10 This formula should be adjusted for BSA to increase its accuracy and compare normal values.
14 It appears to be less accurate in the obese, those of different ethnicities, different age groups, children and pregnant women. 1 The original MDRD equation has six variables, including urea and albumin which was a limitation This study was conducted primarily to evaluate the performance of C-G and MDRD equations in Omani patients by finding out the relation between CCL cr and eGFR by using C-G (eGFR C-G ), modified C-G (eGFR mC-G ) and MDRD (eGFR MDRD The inclusion criteria included adult patients who reported to the Internal Medicine Clinic at Polyclinic for a CL cr test. However, patients who had incomplete data or dialysis therapy were excluded; thus 97 of the 255 files reviewed could not be considered, leaving a total of 158 subjects. Demographic data, such as age, gender, weight, height, body mass index (BMI) and BSA, were recorded.
All subjects were analysed for SCr and subjected to 24-hour urine collection to estimate urine volume (V) and urine creatinine (UCr). The CL cr was calculated by the following equation: 5 The CL cr was then adjusted to BSA to get CCL cr in ml/min per 1.73 m² by the following formula, where BSA equals the square root ([height in cm x weight in Kg]/3600): 8, 16 Depending on a patient's gender, age and SCr, C-G was used to obtain the predicted CL cr , which was abbreviated as eGFR C-G , as in the following formula: 10 The eGFR C-G (ml/min) was adjusted to BSA (modified C-G) to obtain eGFR mC-G (ml/min per 1.73 m²): eGFR mC-G = eGFR C-G x 1.73/BSA.
The MDRD-4 variable equation was used to obtain eGFR MDRD in ml/min per 1.73 m² by the following formula: 15 The eGFR C-G , eGFR mC-G and eGFR MDRD were compared to CCL cr and statistical analysis was done to find out the correlation between them and to estimate an agreement between them. Data were coded using the Statistical Package for the Social Sciences (SPSS), Version 15 (IBM, Corp., Chicago, Illinois, USA) and summarised using the mean, standard deviation (SD), minimal and maximum values for quantitative variables and number and percentage for qualitative values. Correlations were done to test for linear relations between variables. Logistic regression analysis was done to test for significant predictors of dependent variables. A receiver operating characteristic (ROC) curve was used to test the validity of scores calculated by regression equations. A P value of ≤0.05 was considered statistically significant.
Results
The subjects in the study (N = 158) were predominantly <70 years of age (n = 115), although 43 were ≥70 years. The gender distribution was nearly equal (85 males and 73 females) and 42 were obese while 116 were not considered obese. Of those included in the study, 99 had diabetes (DM) and 59 were non-diabetic. The mean ± SD (range) age was 61.65 The eGFR MDRD , eGFR mC-G and eGFR C-G correlated significantly with CCL cr , with a slightly stronger correlation with eGFR MDRD (r = 0.701, 0.658 and 0.605, respectively; P <0.001).
Studying eGFR MDRD, eGFR mC-G and eGFR C-G at a known cut-off value of 90 found that eGFR mC-G had a higher validity than eGFR C-G and that eGFR MDRD had a higher sensitivity and lower specificity than either eGFR mC-G or eGFR C-G (sensitivity = 97.4, 93.6 and 92.3; specificity = 22.5%, 27.5% and 26.3%, respectively).
The ROC curve analysis showed that the diagnostic accuracy of eGFR mC-G for a diagnosis of CKD was higher than that of eGFR C-G . The eGFR MDRD had a higher area under the curve (AUC) and higher sensitivity and lower specificity than either eGFR C-G or eGFR mC-G [ Figure 1 and Table 1 ].
Regression analysis was performed to predict renal impairment by using eGFR C-G adjusted for age, sex, obesity and DM. A regression equation was applied to calculate the predicted score for each patient (ranging from 0-100). The predicted score was entered in a ROC curve to detect its validity as well as to determine the best cut-off value for diagnosing renal impairment. The same was done for eGFR mC-G and eGFR MDRD for comparison. A ROC curve analysis showed that the eGFR mC-G score had a higher AUC, sensitivity, negative predictive value (NPV) and total accuracy (TA), and lower specificity and positive predictive value (PPV) than the eGFR C-G score. Additionally, the eGFR MDRD score had a higher validity than the eGFR mC-G score [ Figure 2 and Table 2 ].
Regarding the validity among the studied groups, the eGFR MDRD had a higher validity than either eGFR C-G or eGFR mC-G in the obese, diabetic, male or the ≥70-year-old subjects. Comparing the validity of eGFR mC-G and eGFR C-G , this study also showed that eGFR mC-G had higher validity in the ≥70-year-old, male and diabetic subjects; however, in the obese subjects, eGFR mC-G was more sensitive but had less specificity, PPV, NPV and TA than in eGFR C-G [ Table 3 ].
Discussion
GFR is the best index of renal function in health and disease. It can be estimated by measuring the renal clearance of certain substances using exogenous (radioisotopic and non-radioisotopic) filtration markers. However, these methods are impractical and expensive. 17 Endogenous markers such as creatinine have also been used to assess GFR. The accuracy of CL cr may be limited by inaccurate urine collection and creatinine secretion. Not only is urine collection time-consuming and cumbersome, but incomplete collection leads to a reduced CL cr while over-collection leads to an increased CL cr . 8 Moreover, CL cr overestimates the GFR due to tubular creatinine secretion. 5 To compensate for these previous limitations, investigators have devised equations that predict GFR based on SCr, gender, body size, race and age. The most widely used equations are the C-G equation, which produces GFR values in ml/min, and the MDRD equation, which produces GFR values in ml/min per 1.73 m². 18 The C-G equation should be adjusted for BSA to increase its accuracy and enable a comparison with normal values. 14 In this study, we evaluated the performance of the C-G and MDRD equations for estimating the GFR in a cohort of 158 subjects. An important characteristic of the cohort is that it included subjects whose CCL cr ranged from 10.3-196.5 ml/ min per 1.73 m² with sufficient numbers of subjects having CCL cr >60 and <60 (84 and 74, respectively). Thus, the performance of these equations could be assessed over a wide range of kidney function.
Furthermore, because all patients included in this study were Arab, the performances of the C-G and MDRD equations could be assessed in a group of subjects whose anthropometric characteristics are slightly different from those of American or European subjects.
With these different anthropometric characteristics in mind, we compared eGFR MDRD , eGFR mC-G and eGFR C-G with CCL cr . It was found that these equations underestimated GFR in comparison to CCL cr (mean CCL cr , eGFR MDRD , eGFR mC-G and eGFRC-G were 69.52, 62.89, 66.37 and 66.87, respectively). This can be explained by the fact that CCL cr exceeds the true GFR by 19% because of tubular secretion. 5 In their study, Froissart et al. showed that there was a very good global agreement between measured GFR and both eGFR MDRD and eGFR mC-G . On average, eGFR MDRD was only 1.0 ml/ min per 1.73 m² less than measured GFR; eGFR mC-G was only 1.9 ml/min per 1.73 m² greater than measured GFR. However, Froissart et al. ' s study compared eGFR MDRD and eGFR mC-G against GFR measured by 51Cr-EDTA renal clearance, and not CCL cr , and did not evaluate eGFR C-G . 19 Similarly, in 1999, Levey et al. documented that the C-G formula largely overestimated measured GFR. 13 The current study demonstrated that eGFR MDRD , eGFR mC-G and eGFR C-G can replace CCL cr in practice, avoiding the limitations of CCL cr , as evidenced by the significant correlation between them, with a stronger correlation with eGFR MDRD (r = 0.701, 0.658 and 0.605, respectively; P <0.001). These results are supported by a Pakistani study which compared eGFR MDRD and eGFR C-G with CCL cr in 369 cases, revealing a significant correlation between them, with a stronger correlation with eGFR MDRD (r = 0.788 for eGFR MDRD and r = 0.775 for eGFR C-G ). However, that study did not evaluate eGFR mC-G . 18 In 2006, Shoker et al. compared eGFR mC-G and eGFR C-G with CCL cr , documenting that eGFR mC-G gave superior results compared to eGFR C-G , with an overall accuracy in the general and subgroup analysis. 14 Similarly, our results showed that eGFR mC-G had a stronger correlation with CCL cr than eGFR C-G emphasising that the correction for BSA increases the validity of the C-G equation. The difference between the two studies is that eGFR mC-G and eGFR C-G were compared with CL cr in the Shoker et al. study, but in our study they were compared with CCL cr , which is more accurate. In 2012, Alcântara et al. compared eGFR C-G with CCL cr and no significant difference was found between the mean eGFR C-G (64.7 ± 27.4) and the mean CCL cr (68.4 ± 32.6) and a correlation between them was found (r = 0.68; P <0.001). Using lean body weight instead of total body weight to obtain the eGFR C-G , the correlation coefficient was increased to 0.75 (P <0.001). 20 However, Alcântara et al. 's study did not evaluate eGFR mC-G and eGFR MDRD , as in our study.
In studying eGFR MDRD , eGFR mC-G and eGFR C-G as a diagnostic tool for renal impairment, as detected by CCL cr and at a known cut-off value of 90, it was found that eGFR mC-G had a higher validity than eGFR C-G . This emphasises that correction for BSA increases the validity of the C-G equation and that eGFR MDRD had a higher sensitivity and lower specificity than either eGFR mC-G or eGFR C-G . A ROC curve analysis showed that the diagnostic accuracy of eGFR mC-G for diagnosing CKD was higher than that of eGFR C-G , and that eGFR MDRD had a higher sensitivity, higher AUC and a lower specificity than either eGFR C-G or eGFR mC-G . By doing a regression analysis to predict renal impairment, using eGFR C-G , eGFR mC-G and eGFR MDRD adjusted for age, sex, obesity and DM, the ROC curve analysis showed that the eGFR mC-G score had a higher AUC, sensitivity, NPV and TA, and a lower specificity and PPV than that of the eGFR C-G score. Additionally, it showed that the eGFR MDRD score had a higher validity than the eGFR mC-G score. Our results supported those of Srinivas et al., whose study compared eGFR MDRD and eGFR mC-G with GFR measured by 99mTc-DTPA renal clearance in 599 renal donors; this study demonstrated that eGFR MDRD performed better in terms of global bias, precision, correlation and accuracy than eGFR mC-G . 21 Regarding the validity among studied groups, our study showed that eGFR MDRD had a higher validity than either eGFR C-G or eGFR mC-G in males, those with DM, individuals ≥70 years of age and those who were obese. The eGFR mC-G had higher validity in diabetics, males and those ≥70 years of age than eGFR C-G ; however, in the obese subjects, eGFR mC-G was more sensitive but had less specificity, PPV, NPV and TA than eGFR C-G . This was similar to Froissart et al. 's study, which showed that eGFR mC-G had the lowest level of precision for obese subjects. 19 In 2005, Rigalleau et al. compared eGFR MDRD and eGFR mC-G with measured GFR in 160 diabetic patients, and revealed that eGFR MDRD and eGFR mC-G correlated well with measured GFR, while eGFR MDRD underestimated and eGFR mC-G overestimated it. The ROC curve analysis showed that the maximum diagnostic accuracy of eGFR mC-G for diagnosing CKD was lower than that of eGFR MDRD . It was concluded that the MDRD equation is more accurate for the diagnosis of renal failure in diabetic patients. 22 However, eGFR MDRD and eGFR mC-G were evaluated against measured GFR by 51Cr-EDTA clearance and not against CCL cr . The eGFR C-G was not evaluated.
Based on the current study, as well as other studies, it is clear that the measurement of CL cr using a 24-hour urine collection system does not improve the estimate of GFR compared to that provided by the C-G and MDRD equations. Nevertheless, this system provides useful information for the estimation of GFR in individuals with unsual dietary intake (for example in subjects with vegetarian diets or those taking creatine supplements), or abnormal muscle mass (for instance as a result of amputation, malnutrition or muscle wasting). It is also useful for the assessment of diet and nutritional status, and for assessing the patient's status when there is a need to start dialysis. 9 There are several limitations to this study. First, CL cr was used as the reference method for GFR although the measurement of CL cr has many theoretical and practical difficulties. Ideally it should be substituted by inulin or isotope clearances as a reference to verify the accuracy of the results. Second, it would be more relevant to compare C-G and MDRD formulas in a multicentre environment.
Conclusion
C-G and MDRD equations can be used as an alternative to the CL cr test for assessing GFR, thereby avoiding the cumbersome, time-consuming and expensive GFR test. The MDRD formula had better validity in this study than the C-G equation and the validity of the C-G equation was improved by an adjustment to the BSA.
